World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
11078
World Ranking
12682
National Ranking
434

Matthew C. Coffey publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Matthew C. Coffey sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 213 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Matthew C. Coffey D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Matthew C. Coffey sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 59 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Matthew C. Coffey is affiliated with Oncolytics Biotech in Canada and has contributed extensively to research in biochemistry, genetics, molecular biology, and medicine. Their work spans several subfields including oncology, genetics, biotechnology, molecular biology, and pathology and forensic medicine.

The scientist's research focuses primarily on virus-based gene therapy, CAR-T cell therapy, cancer research and treatments, colorectal cancer studies, lymphoma diagnosis and treatment, cancer immunotherapy and biomarkers, and RNA interference and gene delivery.

Notable recent publications include:

  • Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer (2020) in Molecular Cancer Therapeutics
  • BRACELET-1 (PrE0113): Inducing an inflammatory phenotype in metastatic HR+/HER2- breast cancer with the oncolytic reovirus pelareorep in combination with paclitaxel and avelumab. (2023) in Journal of Clinical Oncology
  • Treatment with pembrolizumab in combination with the oncolytic virus pelareorep promotes anti-tumor immunity in patients with advanced pancreatic adenocarcinoma. (2021) in Journal of Clinical Oncology
  • 41P A window-of-opportunity study with atezolizumab and the oncolityc virus pelareorep in early breast cancer (REO-027, AWARE-1) (2020) in Annals of Oncology
  • 619P Pelareorep + atezolizumab and chemotherapy in third-line (3L) metastatic colorectal cancer (mCRC) patients: Interim results from the GOBLET study (2023) in Annals of Oncology

Frequent collaborators include Houra Loghmani, Grey Wilkinson, Richard Trauger, Thomas C. Heineman, and Devalingam Mahalingam.

The scientist's articles are primarily published in Journal of Clinical Oncology, Annals of Oncology, and Molecular Cancer Therapeutics.

Best Publications

  • Reovirus Therapy of Tumors with Activated Ras Pathway

    Matthew C. Coffey;James E. Strong;Peter A. Forsyth;Patrick W. K. Lee

  • The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

    James E. Strong;Matthew C. Coffey;Damu Tang;Pauline Sabinin

  • Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

    Adel Samson;Karen J. Scott;David Taggart;Emma J. West

  • A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.

    Peter Forsyth;Gloria Roldán;Gloria Roldán;David George;Carla Wallace

  • A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer.

    Laura Vidal;Hardev S. Pandha;Timothy A. Yap;Christine L. White

  • Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity

    Fiona Errington;Lynette Steele;Robin Prestwich;Kevin J. Harrington

  • Reovirus Oncolysis of Human Breast Cancer

    Kara L. Norman;Matthew C. Coffey;Kensuke Hirasawa;Douglas J. Demetrick

  • Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients.

    Robert A. Adair;Victoria Roulstone;Karen J. Scott;Ruth Morgan

  • Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus

    Jian Qiao;Hongxun Wang;Timothy Kottke;Christine White

  • Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial.

    C L White;K R Twigger;L Vidal;L Vidal;J S De Bono

  • Systemic Reovirus Therapy of Metastatic Cancer in Immune-competent Mice

    Kensuke Hirasawa;Sandra G. Nishikawa;Kara L. Norman;Matthew C. Coffey

  • Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies

    Eleni Karapanagiotou;Victoria Roulstone;Katie Twigger;Mercel Ball

  • Phase II Trial of Intravenous Administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma.

    Evanthia Galanis;Svetomir N Markovic;Vera J Suman;Gerard J Nuovo

  • Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

    Karishma Rajani;Christopher Parrish;Timothy Kottke;Jill Thompson

  • Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors

    Radharani Gollamudi;Mohammad H. Ghalib;Kavita K. Desai;Imran Chaudhary

  • Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.

    Kimberly P Kicielinski;E Antonio Chiocca;John S Yu;George M Gill

  • Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity.

    E J Ilett;R J Prestwich;T Kottke;F Errington

  • REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer

    Charles Comins;James Spicer;Andrew Protheroe;Victoria Roulstone

  • A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer

    Martijn P. Lolkema;Hendrik-Tobias Arkenau;Kevin Harrington;Patricia Roxburgh

  • Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

    Kevin J. Harrington;Eleni M. Karapanagiotou;Victoria Roulstone;Katie R. Twigger

Frequent Co-Authors

Alan Melcher
Alan Melcher Institute of Cancer Research
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Richard G. Vile
Richard G. Vile Mayo Clinic
Peter Selby
Peter Selby University of Leeds
Gerard J. Nuovo
Gerard J. Nuovo The Ohio State University
Patrick W.K. Lee
Patrick W.K. Lee University of Calgary
Timothy Kottke
Timothy Kottke Mayo Clinic
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
David E. Cohn
David E. Cohn The Ohio State University
Christopher M. Nutting
Christopher M. Nutting Royal Marsden NHS Foundation Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens up diverse career prospects, many of which are becoming increasingly accessible through online education. If you're considering advancing your qualifications, online degree programs offer flexible options suited for busy professionals and recent graduates alike.

For students interested in healthcare leadership, a phd in healthcare administration online can build skills in management and policy, leading to roles in hospitals, clinics, and public health organizations. Aspiring pharmacists may explore pharmd online programs, which combine foundational bioscience with practical, hands-on learning for careers in pharmacy and pharmaceutical research.

Some students prefer specialized clinical paths and can benefit from online dnp programs that remove traditional in-person clinical requirements. For those interested in sports health or fitness, an accredited sports science degree online provides expertise in physiology and athletic performance.

These online programs allow you to tailor your education to your career goals without relocating, making advanced study in Biology and related fields more accessible than ever.

Best Scientists Citing Matthew C. Coffey

Trending Scientists

Recently Published Articles